Guard Therapeutics AB
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery (NCT06475274) | Guard Therapeutics AB | 2024-08-26 |
| Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery (NCT05126303) | Guard Therapeutics AB | 2022-03-31 |
| A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery (NCT04829916) | Guard Therapeutics AB | 2021-03-16 |
Track Guard Therapeutics AB automatically
Every clearance here is in the API, with alerts when new ones post.